Glenosphere Size and Scapular Notch in RSA, Prospective Randomized Study

Scapular notch can be reduced by using bigger glenospheres but in some patients it cannot be implanted because of small size. If small size of glenosphere is used then scapular notch may increase. To improve that situation, eccentricity has been added to some glenospheres to increase glenoid overhanging. The objective is to assess if eccentricity can avoid scapular notch as effectively as bigger glenospheres.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Total Shoulder Arthroplasty

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients undergoing reverse shoulder prosthesis because of rotator cuff disordes andacute fractures

Exclusion criteria

patients with previous surgery
patients with deltoid deficiency
patients with acute infection

Treatment and study plan

Reverse Shoulder Arthroplasty

Device

prosthesis implantation

Other names: Delta X-tend

Primary outcomes

scapular notch development

Time frame: two years

X-ray assessment of scapular notch development

Sponsors and collaborators

Lead sponsor

Hospital del Mar

Other

Registry information

Official study title

Influenze of Glenosphere Size in Scapular Notch Development. Randomized Study Comparing 42 to 38 ECC

Acronym: GSSNRSA

Important dates

Study start: 2014
Primary completion: 2016
Study completion: 2016
First posted: Nov 5, 2018
Registry last updated: Mar 12, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed